India Glycols Limited has informed the Exchange about Action(s) taken or orders passed
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.8 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
India Glycols has disclosed a customs order dated 18 December 2025 (received 29 December 2025) related to its Ennature Bio-Pharma division. The Additional Commissioner of Customs (Import) has confirmed a customs duty short-payment demand of Rs. 32.95 lakh along with applicable interest, and imposed an equal penalty of Rs. 32.95 lakh under the Customs Act, 1962, over the period June 2020 to September 2024. The dispute centres on the customs classification of certain imported goods. The company had already deposited Rs. 44.19 lakh (duty plus interest) under protest before the show cause notice, which has been adjusted against the demand. India Glycols plans to file an appeal, stating that based on legal advice it has a strong case and does not foresee any material impact on its financials or operations.
The financial exposure is limited — roughly Rs. 65.9 lakh in duty plus penalty (plus interest), which is small relative to the company's size. Since the company is appealing and the amount is already substantially deposited under protest, near-term impact on earnings or share price is likely negligible. The disclosure is a routine regulatory compliance update.